Melanotan II 10 mg: Weekly Dosage Reference Explained

Melanotan II is a synthetic melanocortin-receptor peptide studied for pigmentation and other effects. This 10 mg reference explains the linked source's weekly example in simple cards, separating daily amounts from maintenance frequency. It is not an approved tanning medicine, and no safe cosmetic-use regimen is established.

Research classification: Research summary · not a validated human regimen. The Melanotan II 10 mg vial label reports nominal content; it does not state a suitable amount for human use.

The linked research overview describes melanocortin signalling, pigmentation effects and small early human experiments. Pigment changes do not establish a safe cosmetic treatment or protection from UV damage.

Mechanistic findings and early experiments do not by themselves establish clinical efficacy, an approved treatment cycle or equivalence between suppliers' formulations. Interpret claims in the context of the specific experimental model and references.

The linked 10 mg educational chart reports the following example: Week 1: 250 mcg (0.25 mg) once daily; Week 2: 500 mcg (0.5 mg) once daily; Week 3: 750 mcg (0.75 mg) once daily; Weeks 4–8: 1000 mcg (1 mg) once daily. Its separate maintenance example after Week 8 is 500–1000 mcg (0.5–1 mg) on 1–2 occasions per week, not daily. These are source-reported amounts, not a clinically validated escalation schedule. The source's own research overview says no approved safe tanning dose is established. The phone-friendly weekly cards display each amount, frequency and conditional volume together. Volume and U-100 readings assume 10 mg in a final volume of 3 mL; they do not prescribe a diluent or preparation method for Peak's research vial.

For the existing schedule, its evidence caveats and the concentration calculator, see the Melanotan II protocol and vial reference. Figures displayed there are research context, not a personalised prescription.

An exact-matching Peak Peptides Australia 10 mg vial is shown on the research reference page. The product is supplied for in-vitro research, not administration.

Reconstitution cannot be inferred from vial strength alone. Confirm the exact compound, lot, expected appearance, compatible sterile diluent, final volume, transfer method and discard/storage period from validated formulation documentation. BAC water and a 28-day period are not universal defaults. See the illustrated product-specific preparation guide and the abnormal-solution safety guide.

View Peak Peptides Australia's research-only listing and confirm its current labelled strength.

• Melanotan II 10 mg chart — weekly educational example — PeptideDosages.com
• Melanotan II research and safety — no established safe tanning dose — PeptideDosages.com

For clinical decisions, consult a qualified professional and the product information for an approved formulation. Research-only supplier material must not be injected or used to treat a condition. Explore the A–Z research directory to compare evidence categories.